Catheter Market Report by Product Type, End Users and Company Analysis 2026-2034

Catheters Market Size and Forecast 2026-2034

The increasing prevalence of the burden of life-threatening chronic diseases, along with a greater number of surgeries being performed and the growing demand for minimally invasive medical devices, will continue to drive steady growth in the catheter market. Additionally, continuous development regarding advances in catheters and increasing healthcare infrastructure all over the world are some of the factors that further extend market growth. This thus sets up a predicted Catheter Market of US$ 27.43 Billion in 2025 to US$ 57.26 Billion in 2034 at a CAGR of 8.52% from 2026-2034, reflecting continued demand worldwide.

Catheters Market Outlook

Catheters are thin, flexible medical tubes inserted into the body for various purposes, including delivering or removing fluids, administering medications, and accessing specific body parts for diagnostic and therapeutic reasons. They are used in a wide range of settings, from general hospitals and clinics to home healthcare. The common applications of catheters include urinary drainage, cardiovascular interventions, intravenous therapy, dialysis, and minimally invasive surgeries. Catheters are made from materials like silicone, latex, and polyurethane for their compatibility with the body, flexibility, and safety for use over both short and long periods. These include urinary catheters, vascular catheters, cardiac catheters, and other specialty catheters fashioned for special needs.

Catheters have become widely used in the global market as the demand for minimally invasive medical treatments continues to grow globally. The escalating number of patients suffering from chronic diseases such as cardiovascular diseases, diabetes, and kidney failure has propelled the demand for catheters. The global population is currently advancing in age, thus driving the sales of catheters in the global market. Catheter technology continues to improve positively, making it more comfortable to use the device.

Growth Drivers of the Global Catheters Market

Rising Prevalence of Chronic Diseases and Aging Population

An increase in the incidence rate of chronic conditions is also a major force behind the growth of the catheters market on a global level. Chronic conditions such as cardiovascular diseases, diabetes, kidney conditions, and urinary incontinence require lengthy and frequent catheterizations, and the escalating rates of these conditions have placed more people under the constant care and management of healthcare facilities and healthcare service providers. Moreover, the aging population on a global level is more prone to such chronic conditions and, as such, is reflected in the rates and willingness to seek medical care within these frameworks. An increase in the overall health expectancy on a global level means more and more people are placed under the care and management of healthcare facilities and service providers. By 2030, 1 in 6 people worldwide will be aged 60 years or over. By then, the number of the population aged 60 and over will have increased from 1 billion in 2020 to 1.4 billion. In 2050, the world's population of people aged 60 years and above will reach double that of 2.1 billion. The number of people aged 80 years or over is projected to triple between 2020 and 2050, reaching 426 million.

Growing Adoption of Minimally Invasive Procedures

The increasing rate of minimally invasive procedures in the field of medicine also fuels the demand for catheters. Catheters play a significant role as a tool for minimally invasive procedures or tests, most of which are diagnostic and/or therapeutic procedures. This demand is likely to continue due to the benefits of less recovery time for patients after the procedures and the lower rates of infection. There are also fewer chances of hospitalization after the therapy has been completed. Advances made possible by technology also play a significant role in increasing the demand for catheters. For one thing, it allows for greater precision and safety for patients undergoing the therapy. In January 2025, Biobot Surgical (Singapore) earned the CE certification for the Mona Lisa 2.0, a robotic system that increases precision for those undergoing prostate biopsy and ablation therapy. Mona Lisa 2.0 is part of the minimally invasive system specifically developed to address prostate cancer diagnosis and treatment. This device acts as a robotic-assisted needle planning and/or position planning system to facilitate precise transperineal access.

Technological Advancements and Product Innovation

Development of innovative and continuously upgraded catheter technology is also boosting growth in the catheters market. There is a development of catheters with anti-microbial materials, improved biocompatibility, and higher flexibility. With advancements in medical technology, technology-enhanced catheters are also being developed to assist in accurate diagnostics after their installation in the human body. In recent years, R&D investment in the development of new and innovative catheter technology has led to their acceptance in the market. The increased quest by healthcare administrators to deploy these medical devices to improve healthcare outcomes for their patients has boosted their uptake and increased their popularity in the global market. Feb. 2025 - Johnson & Johnson MedTech unveiled the release of the CEREGLIDE(TM) 92 catheter System, which is the "next generation" .092" catheter, complemented with the INNERGLIDE 9 aid, that is "indicated to aid in the insertion and guidance of devices in the neurovascular space." The CEREGLIDE 92 System is a .092" inner diameter catheter, "enabling large distal access to aid in the insertion of devices in the M1i territory to aid in flow reduction in the M1i, when performing revascularization of patients suffering from acute ischemic strokeiii."

Challenges of the Global Catheters Market

Risk of Catheter-Associated Infections

One of the major challenges in the catheters market is the risk of catheter-associated infection, such as catheter-associated UTIs and bloodstream infection. Improper insertion, along with prolonged use and inadequate hygiene, may result in serious complications that increase patient morbidity and healthcare costs. These risks could limit the growth of the catheter usage or impose strict clinical guidelines, impacting market growth. Training, monitoring, and infection control measures would thus call for investment by healthcare providers, which adds operational complexity.

Stringent Regulatory Requirements and Product Recalls

Challenges facing the global catheters industry include the issue of challenging regulatory approvals and subsequent compliances. In the industry, it is essential that the products meet very high and strict safety, efficiency, and quality conditions, and the occurrence of product recall due to product defects may have severe implications on the product's brand and lead to substantial financial losses. Regulatory environments in different markets have remained challenging, and this remains a key issue facing catheters manufacturers.

TMVR Catheters Market

The market for TMVR (Transcatheter Mitral Valve Replacement) catheters is boosted by the increasing trend of using minimally invasive therapy for treating patients suffering from mitral valve dysfunction. TMVR catheters provide a minimally invasive alternative to traditional valve replacement surgery, thereby helping patients with higher and greater levels of such dysfunction and those of advancing age. In addition, TMVR catheters have further growth factors such as the increasing percentage of patients suffering from mitral regurgitation and the increasing availability of such catheters to treat patients using minimally invasive catheterization-based heart therapy. Other factors such as clinical trials and product approval also boost the market for TMVR catheters; this is a highly promising and growing market as a result of increasing demand for minimally invasive heart therapy.

Biological Tissue Catheters Market

The biological tissue catheters market involves biological or bioengineered material-based catheters, which have shown improvements in terms of tissue bio-compatibility and reduced bio-reactivity. These catheters have shown greater promise in terms of minimizing complications, thereby paving their way in long-term medical applications. Increasing demand and use of safe and patient-suitable medical devices have contributed to the use of biological tissue catheters. Scientific developments in tissue engineering and biological materials have paved the way in designing bio-similar tissue catheters. Though there is an increased cost attached to using biological tissue catheters, when looking at positive clinical outcomes and patient-suitability, biological tissue catheters have gained importance.

Catheters Hospitals Market

Hospitals account for the largest end-user segment in terms of the catheter market due to the high number of patients under care and the presence of the most advanced diagnostic and interventional capabilities. These catheters find extensive application in medical care, including cardiovascular interventions, urinary drain catheters, intravenous catheters, etc. The growing number of interventions in the hospital setting is also driving the demand for catheters. Advanced catheter utilization is seen in the medical arena, ensuring safety and the best outcome in all patients. Hospital infrastructure developments, including emerging countries, play a major role in the growth of this segment. Hospitals hold the key in healthcare scenarios; therefore, this segment continues to hold the maximum demand in the global catheter market.

Catheters Transfemoral Approach Market

The Transfemoral Approach Catheters Market is expanding to meet the increasing demand for these catheters, which are commonly used in minimally invasive cardiovascular surgeries. The Transfemoral Approach method is the most common practice for accessing the vascular system through the femoral artery, providing a minimally invasive option to surgical access. Transfemoral Approach Catheters have advantages over traditional catheters in minimizing recovery time, causing fewer complications, and increasing patient comfort. With the increasing popularity of minimally invasive cardiovascular surgeries, the Transfemoral Approach Catheters Market is expanding.

Catheters Aortic Stenosis Market

The market for catheters aortic stenosis is driven by increasing prevalence, especially among the aging population. The preference of treatment in catheter-based interventions like TAVR for high- or intermediate-risk surgical patients also fuels this market. Specialized catheters are required for delivering the valves with accuracy and safety. Development in technology has enhanced catheter performance and minimized procedural risks, thus extending indications to lower-risk patients also. Increasing awareness among people about early diagnosis and minimally invasive treatment options is further boosting market growth. Demand for catheters in this category is likely to show stable growth with the growing incidence of aortic stenosis worldwide.

United States Catheters Market

The catheters market in the United States is one of the largest in the world. It is due to its advanced healthcare infrastructure and the fact that it has a number of medical procedures. Catheters market themselves can be used for cardiovascular, urological, dialysis, and cancer diagnosis. Additionally, the country has a high-suffering frequency of chronic conditions, which may be a boon for catheters. A strong trend towards minimally invasive treatments, combined with access to some of the finest catheter technologies, makes the country an important market for catheters. Also, reimbursement for medical treatments is on the higher side, which makes it an advantage for catheters. Further, the country also has a number of medical device manufacturers, which again propels the need for catheters. A growing number of surgeries and an aging population make it a promising market for catheters. March 2025, Shockwave Medical, Inc., a constituent of Johnson & Johnson MedTech, today announced the United States launch of its Javelin Peripheral Intravascular Lithotripsy (IVL) Catheter for the treatment of Peripheral Artery Disease.

United Kingdom Catheters Market

The UK Catheters market excellent support from a well-established public healthcare system along with a rapidly increasing interest in minimally non-surgical procedures. The public healthcare system in the UK relies heavily on minimally non-surgical procedures like catheters. Due to the rapidly increasing rate of chronic diseases and the elderly population in the UK, the demand for catheters in the UK market is rising at a tremendous rate. Though there can be certain problems in public healthcare in terms of high-product demand owing to a lack of budget, the UK market can be said to be steadily growing in terms of demand. The support from regulatory standards enables consistency in demand from healthcare facilities in the UK. This supports the demand from the UK market. November 2025 - Mediplus has further enhanced its award-winning S-Cath(TM) System range of suprapubic catheters with the introduction of S-Cath(TM) System Long - longer system components and more features to give healthcare professionals more choice, greater flexibility, and more user-friendly attributes.

India Catheters Market

India catheters market is witnessing high growth due to the development of the country's healthcare infrastructure and the increasing awareness of minimally invasive procedures. Additionally, the increasing incidence of lifestyle disorders and the aged segment of the population provide further impetus to the catheters market. The demand for cost-effective catheters continues to be dominant in the Indian catheters market, although the trend of high-end catheters can be observed in some of the urban cities in the country. Government initiatives in improving the overall reach of the Indian healthcare sector and the increasing participation of the private sector and the Indian catheters market in the form of medical tourism remain key drivers of the catheters market in the Indian scenario.

Saudi Arabia Catheters Market

The Saudi Arabia catheters market is growing, supported by government-led healthcare modernization and the rising prevalence of chronic diseases. Investments in advanced hospitals and specialized medical care centers increase access to catheter-based treatments. Major indications of cardiovascular diseases, diabetes, and renal disorders drive demand for catheters. The country remains highly dependent on imported medical devices, including catheters of advanced technology. The increasing adoption of minimally invasive procedures and the focus on improving patient outcomes further support the market growth. While cost considerations and regulatory compliance pose challenges, the expansion of healthcare infrastructure along with increasing spending on health positions Saudi Arabia as an emerging market for catheter products. In April 2025, Saudi Arabia's King Faisal Specialist Hospital introduced a state-of-the-art minimally invasive artery stent technique using catheters for treating peripheral artery disease. The minimally invasive procedure can be performed through the thigh, with bioresorbable stents set up to restore blood flow before eventually dissolving and thus reducing surgery and long-term complications.

Market Segmentation

Type

• TAVR
• TMVR
• TPVR

Material

• Mechanical tissue
• Biological tissue

End-User

• Hospitals
• Ambulatory surgical centers
• Others

Product

• Transfemoral approach
• Transapical approach
• Transaortic approach
• Others

Application

• Aortic Stenosis
• Aortic Regurgitation
• Others

Region

North America

• United States
• Canada

Europe

• France
• Germany
• Italy
• Spain
• United Kingdom
• Belgium
• Netherland
• Turkey

Asia Pacific

• China
• Japan
• India
• South Korea
• Thailand
• Malaysia
• Indonesia
• Australia
• New Zealand

Latin America

• Brazil
• Mexico
• Argentina

Middle East & Africa

• Saudi Arabia
• UAE
• South Africa

All companies have been covered with 5 Viewpoints

• Overviews
• Key Person
• Recent Developments
• SWOT Analysis
• Revenue Analysis

Company Analysis:

• Abbott Laboratories
• Becton Dickinson and Company
• Boston Scientific Corporation
• Teleflex Incorporated
• Medtronic Plc.
• Johnson & Johnson
• Edwards Lifesciences Corporation
• Stryker Corporation